Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Billing Codes

HCPCS Code Q4107: Graftjacket billing, fee schedule and Medicare coverage

Key Takeaways

Key Takeaways

HCPCS Code Q4107 describes Graftjacket (acellular dermal matrix), billed per square centimeter as an add-on code alongside a primary wound care procedure code

Q4107 is a temporary Q-series HCPCS Level II code maintained by CMS; it cannot be billed alone and must accompany a qualifying primary wound care code

Medicare coverage under LCD L30135 requires documented wound chronicity, failure of conservative treatment, and wound measurement at each visit before Q4107 claims are paid

Pabau’s claims management tools help wound care practices link Q4107 to the correct primary codes, calculate per-square-centimeter units, and maintain audit-ready documentation

Skin substitute claims are among the most scrutinized in Medicare wound care billing. Q4107 add-on claims for Graftjacket fail at a higher rate than primary wound care codes because coders miss the unit-calculation step, omit the required primary code pairing, or submit without the wound chronicity documentation that Medicare’s Local Coverage Determination requires. This reference covers the 2026 fee schedule, add-on billing rules, ICD-10 crosswalk, coverage criteria, and documentation checklist for HCPCS Code Q4107 so your claims are complete before submission.

HCPCS Code Q4107: code description and key details

HCPCS Code Q4107 describes Graftjacket, per square centimeter. It is a temporary HCPCS Level II Q-series code assigned and maintained by the Centers for Medicare and Medicaid Services (CMS) to identify the application of the Graftjacket Regenerative Tissue Matrix skin substitute in a wound care encounter.

Field Detail
HCPCS code Q4107
Official descriptor Graftjacket, per square centimeter
Code category HCPCS Level II, Q-series temporary code
Code type Add-on code (list separately in addition to primary wound care code)
Product Graftjacket Regenerative Tissue Matrix (acellular human dermis, Wright Medical / Stryker)
Unit of measure Per square centimeter (cm²) of graft applied
Maintained by CMS (Centers for Medicare and Medicaid Services)

Graftjacket is an acellular dermal matrix derived from human dermis. The product undergoes processing to remove cellular material while preserving the extracellular collagen scaffold, which supports tissue regeneration. Because it is derived from human dermal tissue, it falls within the bioengineered skin and soft tissue substitute category covered under LCD L30135. Practices using claims management software can flag Q4107 as a product code requiring a paired primary wound care code to prevent standalone submission errors.

Automate claims through Healthcode
Automate claims through Healthcode

Clinical applications: when Q4107 is used

Graftjacket is applied to chronic wounds that have failed standard conservative treatment. The two primary indications covered under Medicare LCD L30135 are diabetic foot ulcers (DFU) and venous leg ulcers (VLU). Both conditions share the requirement for documented wound chronicity before a skin substitute claim is payable.

  • Diabetic foot ulcers (DFU): Full-thickness wounds on the plantar or dorsal surface of the foot in patients with diabetes. Per LCD L30135 guidance, the wound must typically have been present for at least four weeks and failed standard wound care before Graftjacket application is covered.
  • Venous leg ulcers (VLU): Wounds of venous origin on the lower leg. Standard care failure documentation must accompany the claim, including evidence of compression therapy compliance.
  • Pressure injuries (limited coverage): Some payers cover Graftjacket application to pressure injuries at Stage III or IV where conservative measures have failed, though Medicare coverage for this indication varies by contractor. Verify with your specific Medicare Administrative Contractor (MAC) before billing.
  • Surgical wounds with tissue deficit: Selected post-operative wounds requiring dermal reconstruction; coverage criteria are case-specific and typically require prior authorization outside routine wound care billing.

Wound care clinics managing these patient populations benefit from structured clinical documentation workflows that capture wound type, duration, and prior treatment history at every visit, since each of those data points feeds directly into the Q4107 coverage determination.

How to bill Q4107: add-on code rules and billing guidelines

Q4107 add-on billing failures account for a significant proportion of skin substitute claim denials. The most common errors are submitting Q4107 without a primary code and calculating units incorrectly. The rules below follow AAPC HCPCS Level II coding guidance and CMS claims processing requirements.

Primary codes that must accompany Q4107

Q4107 cannot be billed as a standalone code. It must be reported on the same claim as a qualifying primary wound care procedure code. Commonly paired primary codes include:

  • 97597: Debridement, open wound; first 20 cm² or less
  • 97598: Debridement, open wound; each additional 20 cm² (add-on to 97597)
  • 97602: Wound(s), cleansing of a wound; without anesthesia, 6 cm² or larger
  • 15271: Application of skin substitute graft to trunk, arms, or legs; first 25 cm²
  • 15272: Application of skin substitute graft; each additional 25 cm² (add-on to 15271)
  • 15273: Application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 25 cm²

Unit calculation: per square centimeter

Bill one unit of Q4107 for each square centimeter of Graftjacket applied. Measure the wound surface area at the time of application and document the measurement in the clinical record. Round to the nearest whole square centimeter. Overbilling units relative to documented wound size is a common audit trigger.

Example: A wound measures 4 cm x 3 cm (12 cm²). Bill Q4107 x 12 units alongside the appropriate primary application code.

Modifier usage

  • Modifier 59: Distinct procedural service. Use when Q4107 is billed on the same date as another skin substitute code for a different wound site to indicate a separate and distinct service.
  • Modifier KX: Required by some MACs to indicate that the Medicare coverage criteria (wound chronicity, conservative treatment failure) have been met. Check your MAC’s LCD policy for applicability.
  • Modifier GY: Item or service statutorily excluded. Use when billing a non-covered indication so Medicare generates an official denial for secondary payer purposes.

Practices running billing compliance workflows should build a pre-submission checklist that flags any Q4107 claim missing a primary code or unit entry before the claim reaches the clearinghouse.

Q4107 fee schedule 2026: Medicare reimbursement rates

Medicare Part B reimburses Q4107 per square centimeter under the Physician Fee Schedule (PFS). Rates differ between facility and non-facility settings. Because CMS updates PFS rates annually, the figures below reflect the 2026 schedule. Verify current rates using the CMS Physician Fee Schedule lookup tool for your specific geographic area, as Geographic Practice Cost Index (GPCI) adjustments apply by locality.

Setting 2026 Medicare rate (per cm²) Notes
Non-facility (office) Verify via CMS PFS lookup Higher rate; product and professional work included
Facility (hospital/ASC) Verify via CMS PFS lookup Lower rate; facility overhead reimbursed separately
Commercial payers Contracted rate (varies) Negotiate per payer contract; not CMS-governed

CMS does not publish a single national allowable for Q4107 because rates vary by locality. The research data available does not include verified 2026 per-cm² dollar figures, so avoid using third-party rate aggregators as your billing source of truth. Pull rates directly from the CMS PFS search tool using your practice’s locality code. Commercial payer rates are set by contract and are not bound by the Medicare PFS.

Pro Tip

Download the CMS Physician Fee Schedule file for your locality at the start of each calendar year and load it into your billing system. Per-cm² rates for Q-series skin substitute codes often change with annual PFS updates, and relying on the prior year’s figures is a common source of underbilling or claims adjusted on payment.

Medicare coverage criteria for Q4107

Medicare covers Q4107 under LCD L30135 (Bioengineered Skin and Soft Tissue Substitutes). Coverage is conditional; the claim is payable only when the following criteria are met, per the LCD guidance currently active in your MAC’s jurisdiction. Always verify the current version of L30135, as LCDs are subject to revision.

  • Wound type: Full-thickness diabetic foot ulcer or venous leg ulcer (or other wound type specified in the applicable contractor LCD).
  • Wound duration: The wound has typically been present for at least four weeks prior to skin substitute application.
  • Conservative treatment failure: Standard wound care (debridement, moisture-retentive dressings, off-loading for DFU, compression for VLU) has been attempted for a minimum duration without adequate healing response.
  • Off-loading compliance (DFU): Documented evidence that the patient has used appropriate off-loading during the conservative treatment period.
  • Compression compliance (VLU): Documented evidence of compression therapy before and during skin substitute application.
  • Wound measurements: Wound length, width, and depth recorded at each visit. Progress toward healing must be tracked and documented.
  • No active infection: The wound must be free of active infection at the time of application. Infected wounds require treatment of the infection before skin substitute application is appropriate.

Practices billing for wound care across multiple patient populations benefit from HIPAA-compliant clinical documentation tools that structure coverage criterion capture at the point of care rather than reconstructing it retrospectively for an audit.

Documentation requirements for Q4107 claims

Missing or inadequate documentation is the leading cause of Q4107 denial and recoupment. Medicare and most commercial payers expect the clinical record to demonstrate medical necessity at the time of each application. The checklist below reflects the documentation fields most commonly requested in post-payment audits.

Documentation element What to capture
Wound measurements Length x width x depth (cm) at application visit; same measurements used to calculate Q4107 units
Wound chronicity Date of wound onset; date conservative treatment began; minimum four-week duration documented
Conservative treatment record Type of dressing, frequency of change, debridement performed, off-loading or compression used and duration
Response to treatment Wound healing trajectory; percentage change in wound area across visits; failure to progress despite standard care
Product application details Product name (Graftjacket), lot number, total area applied (cm²), placement technique
Diagnosis and comorbidities Active ICD-10-CM diagnosis codes supporting medical necessity; diabetes management status for DFU claims
Absence of active infection Clinical assessment confirming wound is infection-free at time of application

Structured wound care note templates within digital clinical forms software can pre-populate the measurement fields, prompt for conservative treatment entries, and flag incomplete notes before they reach billing. Practices using wound measurement tracking tools can also produce a longitudinal wound area trend that satisfies the healing-trajectory documentation payers frequently request during audits.

Digital forms
Digital forms

ICD-10 codes commonly used with HCPCS Code Q4107

The ICD-10-CM diagnosis codes submitted with Q4107 must match the covered wound type and be supported by the clinical documentation. The table below lists the codes most frequently paired with Q4107 in wound care billing, organized by wound category. Use the most specific code available, including laterality and wound severity where the ICD-10-CM tabular list requires it.

ICD-10-CM code Description Laterality note
E11.621 Type 2 diabetes with foot ulcer Use with L97.4xx (right) or L97.5xx (left) for site/severity
E11.622 Type 2 diabetes with other skin ulcer Code also non-foot ulcer site using L97 or L98 category
E10.621 Type 1 diabetes with foot ulcer Code also site with L97.4xx or L97.5xx
I83.009 Varicose veins of lower extremity with ulcer, unspecified Specify laterality: I83.001 (right), I83.002 (left)
I83.209 Varicose veins with both ulcer and inflammation, unspecified Specify laterality: I83.201 (right), I83.202 (left)
L97.419 Non-pressure chronic ulcer of right heel and midfoot, unspecified severity Required secondary code for DFU; use with E11.621 or E10.621
L97.519 Non-pressure chronic ulcer of left heel and midfoot, unspecified severity Required secondary code for left-sided DFU

For DFU claims, the diabetic etiology code (E11.621 or E10.621) is sequenced first, with the wound site code (L97.4xx or L97.5xx) as a required secondary code. Submitting only the etiology code without the wound site is a common coding error that can trigger a request for additional information. Verify all codes against the current ICD-10-CM tabular list using the CMS annual code list for the applicable fiscal year.

Q4107 belongs to the Q4100 series of temporary HCPCS codes assigned by CMS to identify individual skin substitute products. Each code in the series identifies a specific product billed per square centimeter. Selecting the correct code requires matching the product actually applied to the patient. The codes are not interchangeable.

HCPCS code Product descriptor Source
Q4101 Apligraf, per square centimeter Bovine collagen / human neonatal cells
Q4102 Oasis wound matrix, per square centimeter Porcine small intestine submucosa
Q4103 Oasis burn matrix, per square centimeter Porcine SIS, burn-specific formulation
Q4104 Integra bilayer matrix, per square centimeter Bovine collagen / shark chondroitin sulfate
Q4105 Integra dermal regen template, per square centimeter Collagen scaffold with silicone layer
Q4106 Dermagraft, per 37.5 cm² Human neonatal dermal fibroblasts
Q4107 Graftjacket, per square centimeter Acellular human dermis (Wright Medical / Stryker)
Q4108 Integra matrix, per square centimeter Wound matrix, single layer

Using the wrong Q-code for the product applied is an upcoding or downcoding error with audit and recoupment consequences. Practices managing multiple skin substitute products should use a billing-integrated EHR system that links product selection at the clinical documentation step to the corresponding HCPCS code at the claim submission step, removing the manual lookup from the workflow.

How practice management software supports Q4107 billing

This is the section no code reference database covers. AAPC, FindACode, and similar lookup tools tell you what Q4107 means. They cannot tell you whether your clinic is applying it correctly across every patient encounter, catching unit calculation errors, or maintaining the wound documentation trail that survives a post-payment audit.

Three workflow gaps drive most Q4107 billing problems in wound care practices:

  • Disconnected documentation and billing: The clinician records wound measurements in one system; the biller enters units manually in another. Transcription errors between those two steps are where unit mismatches originate. Integrated practice management platforms pass the wound area directly to the billing module, so the unit count matches what is documented every time.
  • Missing primary code linkage: Add-on codes require a primary code on the same claim. When scheduling, documentation, and billing run in separate systems, the primary code is sometimes omitted at submission. Rules-based claim scrubbing in integrated claims management software flags an orphan Q4107 before it reaches the payer.
  • Incomplete longitudinal wound records: A single clean note at the application visit is rarely enough. Payers reviewing Q4107 claims in a post-payment audit want to see wound measurements across multiple preceding visits, conservative treatment notes, and off-loading or compression compliance documentation. A platform with structured wound note templates, like those within Pabau’s digital forms module, captures all of that at each encounter without requiring the clinician to remember every required field.

Wound care practices billing significant volumes of Q-series skin substitute codes benefit from skin clinic software that connects clinical documentation, billing rules, and audit-readiness in a single platform. For dermatology and wound care settings specifically, dermatology EMR software with built-in wound tracking removes the documentation gaps that generate most skin substitute denials.

Reduce skin substitute billing errors with integrated documentation

Pabau connects wound measurement, clinical notes, and billing in one platform. Link Q4107 add-on codes to primary procedures, auto-populate unit counts from documented wound area, and maintain the longitudinal wound records Medicare auditors expect.

Pabau practice management software for wound care billing

Q4107 code history and 2026 status

Q4107 is an active HCPCS Level II code as of the 2026 code year. CMS maintains the Q4100 series of skin substitute codes and updates them through the annual HCPCS Level II update process. Verify the current effective status of Q4107 using the CMS HCPCS overview and annual code files or through an HCPCS lookup tool that mirrors the official CMS data.

Year Status Notes
2026 Active No descriptor change reported for 2026; confirm via CMS HCPCS annual file
Q-series review Annual CMS reviews temporary Q-codes annually; codes can be revised, replaced, or deleted
LCD L30135 Active (verify current version) LCD coverage criteria are subject to revision; always check your MAC’s current policy

Because Q-series codes are temporary by design, practices should run an annual code review at the start of each fiscal year to confirm that Q4107 and any other Q-series skin substitute codes in use remain active and unchanged. A code that has been deleted or reassigned mid-year creates claim rejections that can take weeks to resolve. The best EMR software for wound care settings supports annual code library updates so your billing team does not rely on memory to catch retired codes.

Pro Tip

Set a calendar reminder for January of each year to cross-check your active Q-series skin substitute code list against the CMS HCPCS annual update file. Products in the Q4100 series are reviewed annually and can be deleted, renumbered, or have their descriptors revised. Catching a change before you submit the first claim of the year prevents a billing disruption that takes weeks to unwind.

Conclusion

Q4107 claims fail most often for three reasons: no primary code on the claim, unit counts that do not match the documented wound area, and conservative treatment records that cannot support a medical necessity determination. The code rules and documentation standards above address all three. For practices billing Q-series skin substitute codes at volume, the real compliance challenge is not knowing the rules; it is applying them consistently across every encounter without manual errors.

Pabau’s integrated documentation and practice management platform connects wound measurement, clinical notes, and claim scrubbing so Q4107 billing is accurate from the point of care through submission. To see how Pabau handles skin substitute billing workflows, book a demo.

Continue your research

Continue your research

Managing wound care billing across your whole practice? HIPAA compliance for medical offices covers the documentation and security requirements that apply to clinical records used in billing audits.

Want to streamline clinical documentation for wound care visits? Pabau’s measurements tracking software captures wound dimensions across visits, producing the longitudinal wound record that Medicare auditors expect for skin substitute claims.

Exploring EMR options for a multi-clinician wound care practice? Med spa compliance guidance outlines the operational compliance framework that applies across clinical settings managing regulated procedures and billing codes.

Frequently Asked Questions

What is HCPCS Code Q4107 used for?

HCPCS Code Q4107 is used to bill for the application of Graftjacket, an acellular human dermis skin substitute, per square centimeter. It is reported in wound care encounters where Graftjacket is applied to a chronic wound such as a diabetic foot ulcer or venous leg ulcer, alongside a qualifying primary wound care procedure code.

Is Q4107 an add-on code?

Yes. Q4107 is an add-on code and cannot be billed alone. It must be reported on the same claim as a primary wound care or skin substitute application procedure code, such as CPT 97597, 97602, or 15271. Submitting Q4107 without a primary code will result in claim rejection.

What documentation is required to bill Q4107?

Required documentation includes: wound measurements (length x width x depth) recorded at the application visit, wound chronicity evidence (onset date and minimum four-week duration), notes on failed conservative treatment, the product lot number and total area applied, and confirmation that no active infection was present. For Medicare, documentation must also support the LCD L30135 medical necessity criteria.

What ICD-10 diagnosis codes are used with Q4107?

The most common ICD-10-CM codes paired with Q4107 are E11.621 (type 2 diabetes with foot ulcer) and E10.621 (type 1 diabetes with foot ulcer), each requiring a secondary wound site code from the L97 category for laterality and severity. For venous leg ulcers, I83.009 and I83.209 are commonly used, with laterality specified at the fifth or sixth character level.

Does Medicare cover Q4107 Graftjacket?

Medicare Part B covers Q4107 under LCD L30135 when the clinical criteria are met: the wound is a full-thickness DFU or VLU that has been present for at least four weeks, conservative wound care has failed to produce adequate healing, and off-loading or compression compliance is documented. Coverage is subject to your MAC’s current version of the LCD; always verify the active policy before billing.

What is the difference between Q4107 and other skin substitute codes?

Each code in the Q4100 series identifies a specific commercial skin substitute product. Q4107 identifies Graftjacket (acellular human dermis from Wright Medical / Stryker) specifically. Adjacent codes such as Q4101 (Apligraf) and Q4106 (Dermagraft) identify different products with different biological sources and formulations. Using the wrong Q-code for the product applied is a coding error with audit and recoupment consequences; always match the code to the actual product used.

What primary procedure codes must be billed with Q4107?

Q4107 is typically billed alongside CPT codes 15271 or 15273 (skin substitute graft application, first 25 cm²), or with debridement codes such as 97597 or 97602 when debridement is the primary procedure at the same encounter. The specific primary code depends on the procedure performed and the wound location. Confirm the appropriate primary code against current CPT guidelines and your payer’s coverage policy.

×